Risks and management of hypertension in cancer patients undergoing targeted therapy: a review
Abstract Background Rapid progress over the last decade has added numerous agents targeting specific cellular signaling pathways to the treatment armamentarium for advanced cancer. However, many of these agents can cause hypertension resulting in major adverse cardiovascular event. Methods and resul...
Saved in:
Main Authors: | Xiaolei Zhu (Author), Shenhong Wu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk of hypertension in Cancer patients treated with Abiraterone: a meta-analysis
by: Xiaolei Zhu, et al.
Published: (2019) -
Risk of hypertension in cancer patients treated with abiraterone: a meta-analysis
by: Xiaolei Zhu, et al.
Published: (2019) -
The Utility of 24-h Ambulatory Blood Pressure Monitoring for the Diagnosis and Management of White Coat Hypertension in a Primary Care Setting
by: Xiaolei Zhu, et al.
Published: (2022) -
Management of patients on anticoagulant therapy undergoing dental extractions: a systematic review
by: Patricio Oliva-Mella, et al.
Published: (2016) -
Exercise and consumption of herbal remedies decrease the risk of strokes in hypertension and diabetes mellitus patients undergoing a standard therapy
by: Akrom Akrom, et al.
Published: (2019)